Clonal success of piliated penicillin nonsusceptible pneumococci

K Sjöström1, C Blomberg, J Fernebro

  • 1Department of Bacteriology, Swedish Institute for Infectious Disease Control, SE-171 82 Solna, Sweden.

Insights

The Spain(9V)-3 clone (ST156) significantly increased pneumococci nonsusceptible to penicillin (PNSP) in Sweden. A pilus islet (rlrA) present in ST156 strains enhances bacterial carriage success.

Area of Science:

  • Microbiology
  • Genetics
  • Epidemiology

Background:

  • Antibiotic resistance in *Streptococcus pneumoniae* is driven by successful clones.
  • The Spain(9V)-3 clone (ST156) is a highly successful clone associated with reduced penicillin susceptibility (PNSP).

Purpose of the Study:

  • To investigate the clonal composition of PNSP isolates in Sweden.
  • To identify genetic factors contributing to the success of resistant pneumococcal clones.

Main Methods:

  • Molecular characterization of PNSP isolates using sequence typing (ST).
  • Microarray and PCR analysis to detect the rlrA pilus islet.
  • Competitive growth experiments in an animal model of carriage.

Main Results:

  • A dramatic increase in PNSP isolates was observed in Sweden (2000-2003), largely due to the ST156 clone.
  • The ST156 clone expanded significantly within serotype 14 and dominated serotypes 9V and 19F.
  • All ST156 isolates, regardless of capsular type, carried the rlrA pilus islet, also found in the penicillin-sensitive ancestor ST162.
  • Strains with the rlrA pilus islet showed increased success in carriage models.

Conclusions:

  • The rlrA pilus island is a key factor contributing to the success of ST156 and other PNSP clones.
  • This genetic element likely plays a significant role in pneumococcal colonization and spread, independent of antibiotic usage levels.

Related Concept Videos

Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Antibiotic Selection00:57

Antibiotic Selection

Overview